» Articles » PMID: 29202182

Capped RNA Primer Binding to Influenza Polymerase and Implications for the Mechanism of Cap-binding Inhibitors

Overview
Specialty Biochemistry
Date 2017 Dec 5
PMID 29202182
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation ('priming state') and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the 'apo' state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the 'apo' state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive 'apo' state.

Citing Articles

Conformational Dynamics of Influenza A Virus Ribonucleoprotein Complexes during RNA Synthesis.

Carlero D, Fukuda S, Bocanegra R, Ando T, Martin-Benito J, Ibarra B ACS Nano. 2024; .

PMID: 39013014 PMC: 11295199. DOI: 10.1021/acsnano.4c01362.


The Influenza A Virus Replication Cycle: A Comprehensive Review.

Carter T, Iqbal M Viruses. 2024; 16(2).

PMID: 38400091 PMC: 10892522. DOI: 10.3390/v16020316.


The host RNA polymerase II C-terminal domain is the anchor for replication of the influenza virus genome.

Krischuns T, Arragain B, Isel C, Paisant S, Budt M, Wolff T Nat Commun. 2024; 15(1):1064.

PMID: 38316757 PMC: 10844641. DOI: 10.1038/s41467-024-45205-2.


Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining.

Zhang T, Jiang S, Li T, Liu Y, Zhang Y ACS Omega. 2023; 8(28):25165-25184.

PMID: 37483233 PMC: 10357434. DOI: 10.1021/acsomega.3c02243.


Revisiting Viral RNA-Dependent RNA Polymerases: Insights from Recent Structural Studies.

Ramaswamy K, Rashid M, Ramasamy S, Jayavelu T, Venkataraman S Viruses. 2022; 14(10).

PMID: 36298755 PMC: 9612308. DOI: 10.3390/v14102200.


References
1.
Farmer L, Clark M, Boyd M, Perola E, Jones S, Tsai A . Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2. ACS Med Chem Lett. 2017; 8(2):256-260. PMC: 5304291. DOI: 10.1021/acsmedchemlett.6b00486. View

2.
McCoy A, Grosse-Kunstleve R, Adams P, Winn M, Storoni L, Read R . Phaser crystallographic software. J Appl Crystallogr. 2009; 40(Pt 4):658-674. PMC: 2483472. DOI: 10.1107/S0021889807021206. View

3.
Geerts-Dimitriadou C, Zwart M, Goldbach R, Kormelink R . Base-pairing promotes leader selection to prime in vitro influenza genome transcription. Virology. 2010; 409(1):17-26. DOI: 10.1016/j.virol.2010.09.003. View

4.
Afonine P, Grosse-Kunstleve R, Echols N, Headd J, Moriarty N, Mustyakimov M . Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr. 2012; 68(Pt 4):352-67. PMC: 3322595. DOI: 10.1107/S0907444912001308. View

5.
Reich S, Guilligay D, Pflug A, Malet H, Berger I, Crepin T . Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature. 2014; 516(7531):361-6. DOI: 10.1038/nature14009. View